Sheng Wang
Researcher in pharmacology and structural biology (University of North Carolina at Chapel Hill, based on coauthorship on LSD/psychedelic receptor papers)
Data updated
Papers
Trials
Research Footprint
Sheng Wang appears in 5 tracked papers (2017–2022), most studied alongside Psilocybin, Ketamine and LSD, across Depressive Disorders, Safety & Risk Management and Chronic Pain.
Most-cited paper: Crystal Structure of an LSD-Bound Human Serotonin Receptor (464 citations).
Frequent co-authors: David Nichols, John McCorvy and Bryan Roth.
Background & Research
Sheng Wang appears to be a researcher in the UNC Chapel Hill pharmacology/structural biology ecosystem and is a coauthor on multiple high-profile receptor-structure papers relevant to psychedelics and neuropsychiatric drug discovery. The publication record strongly links him to work on serotonin receptor structural biology, though the web search did not identify a unique personal faculty page or profile to fully verify his current role.
Key Impact
He is notable for contributing to foundational structural biology work on psychedelic receptors, including an LSD-bound human serotonin receptor structure and structure-based discovery of nonhallucinogenic psychedelic analogs.
Collaboration Network
3 collaborators· click a node to visit their profile
Full network →Affiliations
Institutions, companies, and organisations Sheng Wang is associated with.
University of North Carolina at Chapel Hill School of Medicine
The University of North Carolina at Chapel Hill School of Medicine (UNC School of Medicine) is the medical school of the University of North Carolina at Chapel Hill. It provides MD and graduate medical education, conducts biomedical research, and delivers clinical care through UNC Health and UNC Medical Center.
View stakeholder →National Institute of Mental Health (NIMH)
governmentU.S. federal institute defining mental-health research agendas and evidence-generation priorities including psychedelic-relevant studies.
View stakeholder →